HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
He Huang Selected Research
He Huang Research Topics
Disease
187
Neoplasms (Cancer)
11/2022 - 05/2002
51
Leukemia
01/2022 - 11/2004
43
Infections
01/2022 - 11/2002
41
Inflammation (Inflammations)
12/2021 - 08/2007
38
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 11/2004
35
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 04/2002
30
Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 10/2003
28
Fibrosis (Cirrhosis)
07/2022 - 04/2010
27
Multiple Myeloma
12/2022 - 06/2004
27
Heart Failure
01/2022 - 07/2007
27
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2021 - 11/2004
26
Neoplasm Metastasis (Metastasis)
11/2022 - 04/2002
23
Atrial Fibrillation
07/2022 - 11/2005
23
Lymphoma (Lymphomas)
01/2022 - 05/2002
21
Hypoxia (Hypoxemia)
08/2022 - 04/2004
21
Myocardial Infarction
12/2021 - 09/2009
18
Cardiac Arrhythmias (Arrythmia)
01/2022 - 05/2009
18
Hepatocellular Carcinoma (Hepatoma)
01/2021 - 03/2009
17
Body Weight (Weight, Body)
12/2022 - 02/2010
16
Cardiomegaly (Heart Hypertrophy)
09/2020 - 02/2010
15
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2011
15
Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2005
15
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 11/2010
14
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 01/2012
14
Hemorrhage
01/2022 - 09/2012
14
Carcinogenesis
01/2021 - 09/2003
14
Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 12/2007
14
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2020 - 10/2003
13
Neutropenia
11/2022 - 08/2011
13
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2002
13
Carcinoma (Carcinomatosis)
03/2019 - 11/2002
12
Pain (Aches)
01/2022 - 08/2006
12
Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 11/2003
11
Obesity
01/2022 - 01/2017
11
Cytokine Release Syndrome
11/2021 - 01/2016
11
Residual Neoplasm
02/2021 - 11/2003
10
Thrombosis (Thrombus)
01/2022 - 08/2007
10
Hypertension (High Blood Pressure)
01/2022 - 07/2007
10
Hypertrophy
09/2020 - 01/2014
9
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 08/2009
9
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2004
9
Breast Neoplasms (Breast Cancer)
10/2021 - 12/2008
9
Mycoses (Diseases, Fungus)
08/2021 - 05/2013
9
Adenocarcinoma
04/2021 - 11/2002
9
Glioma (Gliomas)
11/2019 - 07/2005
8
Atrial Remodeling
07/2022 - 09/2010
8
Thrombocytopenia (Thrombopenia)
01/2022 - 08/2002
8
Sepsis (Septicemia)
12/2021 - 01/2013
8
Lung Neoplasms (Lung Cancer)
12/2021 - 02/2013
8
Disease Progression
01/2021 - 04/2004
8
Ischemia
01/2020 - 01/2009
8
Acute Promyelocytic Leukemia
01/2020 - 10/2005
7
Nasopharyngeal Carcinoma
11/2022 - 12/2003
7
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 06/2006
Drug/Important Bio-Agent (IBA)
87
Proteins (Proteins, Gene)
FDA Link
11/2022 - 07/2005
52
Chimeric Antigen Receptors
IBA
01/2022 - 01/2016
37
Biomarkers (Surrogate Marker)
IBA
06/2022 - 02/2005
26
Pharmaceutical Preparations
IBA
06/2022 - 08/2002
23
Biological Products
IBA
11/2022 - 07/2005
21
Cytokines
IBA
12/2021 - 05/2010
18
Messenger RNA (mRNA)
IBA
11/2022 - 06/2004
18
MicroRNAs (MicroRNA)
IBA
01/2021 - 10/2008
16
Interleukin-6 (Interleukin 6)
IBA
12/2021 - 06/2004
15
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 11/2002
14
Telomerase (Telomerase Reverse Transcriptase)
IBA
10/2021 - 02/2004
13
Antigens
IBA
01/2021 - 05/2008
13
RNA (Ribonucleic Acid)
IBA
09/2020 - 10/2008
12
Glucose (Dextrose)
FDA Link
Generic
01/2022 - 09/2012
12
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2021 - 09/2009
12
Small Interfering RNA (siRNA)
IBA
09/2020 - 02/2006
10
Peptides (Polypeptides)
IBA
01/2022 - 09/2009
9
Enzymes
IBA
04/2022 - 08/2011
9
Rituximab (Mabthera)
FDA Link
01/2022 - 08/2009
9
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 10/2011
9
Collagen
IBA
01/2021 - 04/2010
9
Imatinib Mesylate (Gleevec)
FDA Link
12/2018 - 05/2009
9
Angiotensin II
IBA
10/2018 - 04/2010
8
Phosphotransferases (Kinase)
IBA
01/2022 - 12/2008
8
Bortezomib (Velcade)
FDA Link
01/2022 - 12/2009
8
Prednisone (Sone)
FDA Link
Generic
01/2022 - 10/2011
8
Sirolimus (Rapamycin)
FDA Link
11/2021 - 04/2008
8
Antibodies
IBA
04/2021 - 01/2011
8
Long Noncoding RNA
IBA
12/2019 - 12/2016
7
Therapeutic Uses
IBA
08/2022 - 06/2010
7
Iron
IBA
07/2022 - 04/2010
7
ruxolitinib
IBA
01/2022 - 12/2019
7
Paclitaxel (Taxol)
FDA Link
Generic
01/2022 - 10/2006
7
Steroids
IBA
01/2022 - 08/2012
Therapy/Procedure
148
Therapeutics
12/2022 - 05/2002
69
Hematopoietic Stem Cell Transplantation
01/2022 - 01/2010
66
Drug Therapy (Chemotherapy)
06/2022 - 08/2002
34
Transplantation
11/2022 - 10/2003
17
Stem Cell Transplantation
01/2021 - 06/2004
14
Immunotherapy
01/2022 - 01/2017
14
Radiotherapy
01/2021 - 03/2011
10
Deep Brain Stimulation
07/2016 - 05/2005
9
Catheter Ablation
01/2022 - 07/2006
9
Stents
11/2021 - 03/2011
9
Neoadjuvant Therapy
01/2021 - 11/2003
8
Ligation
11/2021 - 09/2009